Cargando…

NPM3 as a novel oncogenic factor and poor prognostic marker contributes to cell proliferation and migration in lung adenocarcinoma

BACKGROUND: Lung cancer is the leading cause of cancer-related deaths worldwide, and despite recent advances in targeted therapies and immunotherapies, the clinical benefit remains limited. Therefore, there is an urgent need to further investigate the molecular mechanisms underlying lung cancer. The...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wei, Shan, Xing, Jing, Lu, Kaining, Wang, Kai, Yu, Wanjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10230701/ https://www.ncbi.nlm.nih.gov/pubmed/37254219 http://dx.doi.org/10.1186/s41065-023-00289-6

Ejemplares similares

Determining the contribution of NPM1 heterozygosity to NPM-ALK-induced lymphomagenesis
por: McDuff, Fiona Kate Elizabeth, et al.
Publicado: (2011)

In silico analysis reveals PRR11 as a prognostic and oncogenic marker in lung adenocarcinoma
por: Hu, Ankang, et al.
Publicado: (2023)

SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein()
por: Vishwamitra, Deeksha, et al.
Publicado: (2015)

The Role of Oncogenic Tyrosine Kinase NPM-ALK in Genomic Instability
por: Lobello, Cosimo, et al.
Publicado: (2018)

Functional characterization of NPM1–TYK2 fusion oncogene
por: Kuravi, Sudhakiranmayi, et al.
Publicado: (2022)

NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021)

FOXM1 and CENPF are associated with a poor prognosis through promoting proliferation and migration in lung adenocarcinoma
por: Li, Peipei, et al.
Publicado: (2023)

GNG5 is a novel oncogene associated with cell migration, proliferation, and poor prognosis in glioma
por: Zhang, Wang, et al.
Publicado: (2021)

NPM-ALK: The Prototypic Member of a Family of Oncogenic Fusion Tyrosine Kinases
por: Pearson, Joel D., et al.
Publicado: (2012)

Paraneoplastic Leukocytosis: A Poor Prognostic Marker in Pancreatic Adenocarcinoma
por: Kabashneh, Sohaip, et al.
Publicado: (2020)

HGF and NRG1 protein expression are not poor prognostic markers in surgically resected lung adenocarcinoma
por: Pan, Bin, et al.
Publicado: (2015)

Corrigendum: NPM1 Is a Prognostic Biomarker Involved in Immune Infiltration of Lung Adenocarcinoma and Associated With m6A Modification and Glycolysis
por: Liu, Xu-Sheng, et al.
Publicado: (2021)

Long non-coding RNA, CHRF, predicts poor prognosis of lung adenocarcinoma and promotes cell proliferation and migration
por: Xie, Xiaowei, et al.
Publicado: (2018)

Oncogene TUBA1C promotes migration and proliferation in hepatocellular carcinoma and predicts a poor prognosis
por: Wang, Ji, et al.
Publicado: (2017)

Indeterminate and oncogenic potential: CHIP vs CHOP mutations in AML with NPM1 alteration
por: Cappelli, Luca Vincenzo, et al.
Publicado: (2021)

Overexpression of eIF3D in Lung Adenocarcinoma Is a New Independent Prognostic Marker of Poor Survival
por: Wang, Dan, et al.
Publicado: (2019)

AHNAK2 Is Associated with Poor Prognosis and Cell Migration in Lung Adenocarcinoma
por: Zhang, Shusen, et al.
Publicado: (2020)

Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma
por: Yun, Sumi, et al.
Publicado: (2016)

Correlation between oncogene integrator complex subunit 7 and a poor prognosis in lung adenocarcinoma
por: Li, Zhoubin, et al.
Publicado: (2022)

CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients
por: Shi, Run, et al.
Publicado: (2017)

NMU Is a Poor Prognostic Biomarker in Patients with Lung Adenocarcinoma
por: Tang, Yan, et al.
Publicado: (2021)

CYCLON and NPM1 Cooperate within an Oncogenic Network Predictive of R-CHOP Response in DLBCL
por: Bouroumeau, Antonin, et al.
Publicado: (2021)

Overexpression of LRRC59 Is Associated with Poor Prognosis and Promotes Cell Proliferation and Invasion in Lung Adenocarcinoma
por: Li, Dong, et al.
Publicado: (2020)

Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma
por: Li, Ping, et al.
Publicado: (2016)

Molecular profiling identifies prognostic markers of stage IA lung adenocarcinoma
por: Zhang, Jie, et al.
Publicado: (2017)

LncRNA SNHG17 Contributes to Proliferation, Migration, and Poor Prognosis of Hepatocellular Carcinoma
por: Luo, Yue, et al.
Publicado: (2021)

SERINC2-knockdown inhibits proliferation, migration and invasion in lung adenocarcinoma
por: Zeng, Yuan, et al.
Publicado: (2018)

ACOT11 promotes cell proliferation, migration and invasion in lung adenocarcinoma
por: Liang, Chaoyang, et al.
Publicado: (2020)

Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells
por: Ko, Pin-Hao, et al.
Publicado: (2019)

MARCKSL1 promotes the proliferation, migration and invasion of lung adenocarcinoma cells
por: Liang, Wenjun, et al.
Publicado: (2020)

PROSER2 is a poor prognostic biomarker for patients with osteosarcoma and promotes proliferation, migration and invasion of osteosarcoma cells
por: Li, Zhengjiang, et al.
Publicado: (2022)

Expression of Nucleophosmin/NPM1 correlates with migration and invasiveness of colon cancer cells
por: Liu, Yan, et al.
Publicado: (2012)

DUSP10 upregulation is a poor prognosticator and promotes cell proliferation and migration in glioma
por: Zhou, Fang, et al.
Publicado: (2023)

Retraction: Long Noncoding RNA RGMB-AS1 Indicates a Poor Prognosis and Modulates Cell Proliferation, Migration and Invasion in Lung Adenocarcinoma
Publicado: (2021)

KLF15 promotes the proliferation and metastasis of lung adenocarcinoma cells and has potential as a cancer prognostic marker
por: Gao, Lihua, et al.
Publicado: (2017)

Integrated Bioinformatics Analysis for Identifying the Significant Genes as Poor Prognostic Markers in Gastric Adenocarcinoma
por: Li, Yamei, et al.
Publicado: (2022)

Oncogenic RIT1 mutations in lung adenocarcinoma
por: Berger, A H, et al.
Publicado: (2014)

Oncogenic mutations are associated with histological subtypes but do not have an independent prognostic value in lung adenocarcinoma
por: Hu, Haichuan, et al.
Publicado: (2014)

KPNA2 promotes renal cell carcinoma proliferation and metastasis via NPM
por: Zheng, Song, et al.
Publicado: (2021)

Hypermethylation of BEND5 contributes to cell proliferation and is a prognostic marker of colorectal cancer
por: Lin, Ruo-Kai, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_h1naufdj3p55t37dtcfbrlvv9n